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Summary The incidence of childhood leukaemia in The Netherlands in the period 1973-1986 was studied by
means of the DCLSG nationwide register, which lists all patients according to bone marrow slides classified
in the DCLSG central laboratory. Acute lymphocytic leukaemia (ALL) accounted for 81% of cases, acute
non-lymphocytic leukaemia (ANLL) for 13%, chronic myelocytic leukaemia (CML) for 2.5%, and acute
unclassifiable leukaemia (AUL) for 3%. The peak incidence of ALL was at age 3, common-ALL and pre B-
ALL comprising about 95% of the immunophenotypes at this age. Incidence rates for ALL remained stable
between 1973 and 1978 at 2.85 cases per 10 children per year, exhibited a temporary increase between 1979
and 1984 to 3.60 and dropped back to the lower, previous level in 1985 and 1986. This rise was seen mainly
among children in the 1-4 year age group, especially at age 3, and those with common-ALL and an initial
WBC<5.0xl 91-1. Cumulative incidence rates per year of birth were fairly homogeneous up to age 6,
except for the 1978 birth cohort which exhibited higher rates. Incidence rates for ANLL, CML and AUL
remained stable over time. Changes in ascertainment, declining birth rates and a 50% decrease in childhood
mortality, e.g. from infectious diseases, could not explain this temporary variation. Moreover, incidence rates
in this survey appeared to be similar to those reported in various developed countries for the same period. As
far as the aetiology of childhood common-ALL is concerned, therefore, the Dutch data appear to support the
hypothesis of 'random mutation' as well as that of a limited role of environmental factors.
Since 1973 the occurrence of childhood leukaemia in The
Netherlands has been documented accurately through the
nationwide morbidity register of the Dutch Childhood
Leukaemia Study Group (DCLSG). In a previous
epidemiological study the DCLSG register proved to be
almost complete. The incidence of childhood leukaemia
appeared to be constant in the period 1973-1979 (van
Steensel-Moll et al., 1983a). The present study covers the
period 1973-1986. For acute lymphocytic leukaemia (ALL)
the distributions of the white blood cell counts at diagnosis
(WBC) as well as that of the immunophenotypes have also
been analysed, the latter since 1979.
The aetiology of childhood leukaemia is still unknown,
although severalriskfactorshavebeenidentifiedincase-control
studies performed in The Netherlands (van Steensel-Moll et al.,
1984, 1985a,b, 1986) and elsewhere. Most of the aetiological
studies have focused on ALL, since it accounts for more than
80% ofthecasesindevelopedcountriesandischaracterisedbya
peak incidence for common-ALL between ages 2 and 5.
With regard to the aetiology of childhood ALL, in particular
concerning common-ALL in young children, two major
hypotheses have recently been suggested: a major role for
host-environment interactions (Ramot & Magrath, 1982) or
spontaneous mutation of the rapidly proliferating
lymphocyte progenitors in bone marrow (Greaves, 1986). To
assess the possible role of environmental factors in the
aetiology of childhood ALL in The Netherlands, changes in
demography as well as (competing?) mortality risks for
children in the same period were evaluated.
Patients and methods
Patients
Patient and disease characteristics of children with
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(suspected) leukaemia were collected at the DCLSG through
registration forms, completed by the attending paediatricians
or by specially trained registration assistants in the various
centres for childhood leukaemia. This study comprised 1,596
children, 0-14 years of age, with leukaemia newly diagnosed
between 1 January 1973 and 1 January 1987. Since the
children had to be inhabitants of The Netherlands at the
time of diagnosis, 30 patients were subsequently excluded. In
1980 the completeness of the register was verified by means
of questionnaires sent to all Dutch paediatricians as well as
by comparison with the Eindhoven regional cancer register
in the south-eastern part of the country. Since then
completeness has been checked incidentally by questioning of
individual paediatricians, practising either in border areas of
the country or in centres for childhood leukaemia. Only
minor discrepancies were revealed by annual comparisons
between the aggregate number of patients registered at the
DCLSG since 1980 by age and sex and those registered
according to cause of death with the Department of Health
Statistics of the Central Bureau of Statistics (CBS).
Patients were grouped by sex and age at diagnosis: 0, 1-4,
5-9 and 10-14 years.
Diagnosis
The diagnosis was primarly made by morphological and
cytochemical examination of blood and bone marrow smears
in the hospital laboratory and had to be confirmed in the
central laboratory of the DCLSG. Classification was
performed according to French-American-British (FAB)
criteria (Bennett et al., 1976), resulting in the following
subtypes: acute lymphocytic leukaemia (ALL), acute non-
lymphocytic leukaemia (ANLL). chronic myelocytic
leukaemia (CML) and acute unclassifiable leukaemia (AUL)
whenever FAB-criteria did not fit. In the latter cases
electron-microscopy studies have been performed since 1982.
Myelodysplastic syndromes (MDS) have also been regis-
tered since 1979.
For patients with lymphoblastic malignancies the presence
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in the bone marrow of more than 25% lymphoblasts at
diagnosis was considered characteristic of ALL. Patients
with ALL were grouped according to white blood cell count
(WBC) at diagnosis: 0-4.9, 5-19.9, 20-49.9, 50-99.9 and
> 100.0 x 109 1-1. The WBCs were determined in the
hospitals concerned; data were not available in less than 1%
of cases. Since 1979 immunophenotyping of bone marrow,
obtained at diagnosis from 534 patients, has been carried out
in the Central Laboratory of the Dutch Red Cross Blood
Transfusion Services in Amsterdam. Thirty samples were
typed in the Biochemical Laboratory of the Department of
Paediatrics in the Radboud Hospital in Nijmegen. The
proportion of typed ALL samples has increased gradually
from 60% in 1979 to more than 90% in 1985. With regard
to the variation in the incidence of ALL in young children,
the presence of a correlation between low initial WBCs and
specific immunophenotypes, e.g. common-ALL, can there-
fore only be evaluated accurately from 1984 onwards.
Marker studies included the use of polyclonal antibodies up
till 1983 (van der Reijden et al., 1983) and monoclonal
antibodies since then.
Five subgroups were thus distinguished: T-ALL (aT+), B-
ALL (slg+), common-ALL (c-ALL+, cIgM-), pre B-ALL
(cALL+, cIgM +) and unclassifiable ALL ('Ia'+or-, other
markers absent).
Data analysis
Data analysis was performed in the Department of
Epidemiology of the Erasmus University in Rotterdam.
Annual mid-year population data per year of age, sex, region
and degree of urbanisation were provided by the Department
of Population Statistics of the CBS. With regard to
urbanisation the official classification of municipalities was
applied, leading to a division into rural areas and small and
large cities, the corresponding distribution of the childhood
population being 13.5, 40 and 46.5%, respectively. The
changing age distributions for children in The Netherlands
since 1973 are shown in Table I.
Incidence
Annual incidence rates were calculated per 100,000 children
according to type of leukaemia and sex and age of the
patient. Age adjustment was performed on the basis of the
world standard population, the weights for the above-
mentioned age categories being 7.75, 31, 32.25 and 29%,
respectively. (In the previous study of the period 1973-1979
the Dutch childhood population of 1979 (Table I) was used
as a standard with markedly different weights for the various
age categories, thus resulting in a 25% lower age-adjusted
figure for ALL.)
Incidence rates are presented both per year and as moving
means per three-year periods of diagnosis. The observed
variation in the annual ALL rates for the age group 1-4
years was tested for randomness by means of the One
Sample Run Test (Siegel, 1956). Calculation of the
cumulative rates per year of birth also included the cohorts
of 1971 and 1972, whereby missing incidence data for the
Table I Age distribution of the childhood population in The
Netherlands, 1973-1986. Number of children (thousands), age group
and percentage of childhood population
1973 1979 1986
Age groups
(years) No. % No. % No. %
0 195 5.5 175 5.5 184 6.5
1-4 932 26.5 712 22 695 25
5-9 1,206 34 1,108 34.5 890 32
10-14 1,202 34 1,221 38 1,025 36.5
0-14 3,535 100 3,216 100 2,794 100
Per cent 100 91 79
years before 1973 were assumed to be similar to those in the
period 1973-1975.
International comparison
Incidence data as well as ALL/ANLL ratios were obtained
from the following countries and registers: Denmark in
1980-1984 (J.H. Olsen, personal communication), Finland in
1971-1982 (Finnish Cancer Registry, 1987), West Germany
in 1980-1986 (Kaatsch & Michaelis, 1987), Manchester and
West Midlands in England in 1971-1983, the Leukaemia
Research Fund Data Collection Survey in 1984-1986 (R.
Cartwright, personal communication), the Paediatric Cancer-
Registry of Australia in 1977-1982 and the SEER Program
(1984) in the USA in 1973-1982 (in the latter register white
and black children are listed separately). The data of most of
these registers have been incorporated in an international
collaborative study, the International Incidence of Childhood
Cancer (Parkin et al., 1988).
Mortality data
Data on causes of death for children in The Netherlands
since 1970 were obtained from the Department of Health
Statistics of the CBS. Infectious diseases were grouped
according to the ninth revision of the International
Classification of Diseases: infectious and parasitic diseases
(code 001-136), meningitis and encephalitis (code 320-24)
and bronchitis and pneumonia (code 480-87).
Results
Incidence of childhood leukaemia in 1973-1986
The number of cases and the incidence according to
morphological type and sex are shown in Table II. The
proportional distributions of the various types for boys and
girls are identical, ALL accounting for 81% of cases and
ANLL for 13%. Age-adjusted sex ratios (boys/girls) were
1.16 for ALL and 1.11 for ANLL. The age adjusted ALL/
ANLL ratios were 8.5 for boys and 8.2 for girls. The age
and sex-specific incidence figures for the various types of
leukaemia are presented in Table III. ALL occurred more
frequently in the 1-4 year age group, while ANLL was more
common in infants.
Analysis of the age-adjusted incidence of ALL according
to degree of urbanisation did not reveal any differences for
girls; for boys rates for rural areas, smaller cities and larger
cities were 2.9, 3.2 and 3.3 per 100,000 children per year,
respectively.
Time trend
Annual age adjusted incidence rates for childhood ALL,
ANLL and for all types are presented in Figure 1. Incidence
rates for ALL remained stable between 1973 and 1978 at
2.85 per 105 children per year, increased between 1979 and
1984 to 3.60 and dropped back to the previous level after
1984. This pattern was similar for boys and girls.
Incidence rates for ANLL, CML and AUL were more or
less constant over time. Age-specific incidence rates for ALL
are shown in Figure 2 as three-year moving averages.
Temporary variations in these rates occurred only among
infants and children 1-4 years of age. In the latter group this
variation in the annual rates could still be a random
phenomenon, as tested by the One Sample Run Test
(number of runs=5 for a median value of 5.8 x 105 person
years).
The peak incidence of ALL appears to have occurred at
age 3 since 1977, except in 1980 and 1985 (Figure 3). The
largest fluctuation also proved to be at this age, whereby
rates for 2-year-old patients showed a reversed pattern. A
cohort analysis by year of birth demonstrated similar
cumulative incidence rates in the first five years of life,102 J.W.W. COEBERGH et al.
Table II Age-adjusted incidence and number of cases of childhood leukaemia in The
Netherlands, according to type and sex, 1973-1986
Both sexes Boys Girls
Rate per Rate per Rate per Sex
Type No. % 105 per year No. 105 per year No. 105 per year ratio
Total 1566 100 3.93 867 4.21 699 3.59 1.16
ALL 1264 80.8 3.17 699 3.39 565 2.93 1.16
ANLL 200 12.8 0.47 108 0.49 92 0.44 1.11
CML 40 2.6 0.10 24 0.12 16 0.07 1.70
AUL 48 3.0 0.13 27 0.14 21 0.12 1.16
MDS" 14 0.8 0.06 9 0.07 5 0.04 1.80
aIncluded since 1979.
Table III Age-specific incidence of childhood leukaemia in The
Netherlands according to type and sex, 1973-1986
Cases per 105 per year
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Figure 1 Childhood leukaemia in The Netherlands, 1973-1986:
Annual age adjusted (world standard population) incidence rates
for ALL, ANLL and all types per 100,000 children. (Source:
Dutch Childhood Leukaemia Study Group.)
except that the rate for the birth cohort of 1978 was more
than 30% higher than the average for the other years of
birth (Figure 4).
Childhood ALL: WBC and immunophenotype
The age-specific distribution of ALL according to WBC at
diagnosis is presented in Table IV. More than 75% of ALL
cases (43% of infants) presented with an initial
WBC<50 x 10 -1. An association appeared to exist
between the initial WBC (Table IV) and the sex ratio (boys/
girls): an increase in the WBC corresponded with an increase
Figure 2 Age-specific (0, 1-4, 5-9 and 10-14 years) incidence of
acute lymphocytic leukaemia in children in The Netherlands,
1873-1986: Three-year moving means per 100,000 children per
year. (Source: Dutch Childhood Leukaemia Study Group.)
in the sex ratio, the values being 1.04, 1.12, 1.23, 1.26 and
1.28, respectively. Incidence rates for ALL according to
WBC at diagnosis varied most over time for values
<20 x 1091-1, in particular <5 x 10 1-1 (Figure 5). This
occurred mainly in the 1-4-year-old age group, in particular
at age 3 in 1981, 1982 and 1983 (Figure 3).
The distribution of immunophenotypes according to age is
presented in Figure 6 and according to WBC at diagnosis in
Table V. The most frequent phenotype was common-ALL
since, together with pre B-ALL, it accounted for 74% of all
cases, 90% of those in the age group 1-4 and 95% of those
diagnosed at age 3. (The latter findings are only based on
1985 and 1986 data.) Patients with these phenotypes usually
presented with a low WBC at diagnosis. T-cell ALL did not
exhibit a definite age preference; these patients usually
presented with a WBC> 100.0 x 109 1-1. T-cell ALL occurred
twice as often in boys as in girls, thus partly explaining the
rise in the sex ratio for children with a higher initial WBC.
International comparison
Childhood leukaemia rates in The Netherlands appeared to
be more or less similar to those in countries of identical
socioeconomic development (Table VI). ALL/ANLL ratios
were between 5 and 6 in most registers. The rates for ALL
and the ALL/ANLL ratio among black children in America,
as measured in the SEER Program, were definitely lower.
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and 4) and WBC at diagnosis per 100,000 children. (Source:
Dutch Childhood Leukaemia Study Group.)
Discussion
The DCLSG registration rates most likely reflect the true
incidence of childhood leukaemia in The Netherlands in the
period 1973-1986. These rates appear to be equivalent to
those in countries with similar socioeconomic development
(Table VI), when expressed as the distribution of patients by
age and sex as well as by morphological type of leukaemia.
For ALL this also pertains to the distribution of initial
WBCs and immunophenotypes (Greaves et al., 1985;
McKinney et al., 1987; Stiller, 1985). Between 1979 and 1984
Table IV Age-specific incidence of childhood ALL in The Nether-
lands according to WBC at diagnosis, 1973-1986
Cases per 105 per year
WBC: No. of
leukocytes 0 1-4 5-9 10-14 0-14 No. of
x 109 1-1 years years years years years cases
0- 4.9 0.04 1.64 0.87 0.41 0.91 372
5.0-19.9 0.24 2.17 0.77 0.37 1.09 423
20.0-49.9 0.56 0.88 0.25 0.17 0.45 172
50.0-99.9 0.24 0.43 0.24 0.11 0.26 106
>99.9 0.88 0.62 0.35 0.24 0.45 180
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an increase in the incidence of ALL was observed in young
children in The Netherlands and consequently so was a
larger ALL/ANLL ratio. This temporary increase is partly
attributed to an almost 50% higher cumulative leukaemia
rate for the 1978 birth cohort up to age 6. It was also found
for 3-year-old children with presumed common-ALL and a
low WBC at diagnosis. In contrast, incidence rates for
patients with an initial WBC>50 x109 1-1, 42% of whom
had T-cell leukaemia (Table V), were constant over time.
On the other hand incidence rates for ALL among infants
with 60% of these WBC values showed some fluctuations
(Figure 2); the annual number of such cases was small,
however. In the Manchester region an increase was observed
in the incidence of 1-4-year-old children with ALL and an
initial WBC <50 x 109 l-1 in the period 1970-1977 (Birch et
al., 1981). In a larger study an increased rate was found in
England for the 1974-1978 period, but only in boys with an
initial WBC > lO x 1091-1 (Stiller, 1985). In the Scandinavian
countries age-adjusted rates for childhood leukaemia were
about similar and remained more or less constant from 1965
until 1980 (Hakulinen et al., 1986). In Denmark incidence
rates for ALL in children of age 3 also showed a temporary
increase, thus causing a definite peak in the period
1980-1984.
The two hypotheses concerning the origin of common-
ALL in childhood (Ramot & Magrath, 1982; Greaves,
1986) exhibit a certain degree of agreement: the random
mutation theory does not exclude the possibility of an
influence of exogeneous risk factors. Furthermore, both
hypotheses are based on the observation of similar patterns
of incidence rates for childhood leukaemia in developed
countries, as is confirmed by this study and descriptive
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Figure 6 Acute lymphocytic leukaemia in children in The
Netherlands: Immunophenotype and age 1979-1986. (Source:
Dutch Childhood Leukaemia Study Group.)
studies from cancer registers in the period 1968-1984
(Breslow & Langholz, 1983; Parkin et al., 1988).
In this respect the temporary variation in the incidence of
childhood ALL, as observed in this study, invites
consideration of the following points of interest:
1. Changes in ascertainment might have occurred over
time, especially for young children with common-ALL and a
low initial WBC, because of its protracted natural course.
However, it is unlikely that these changes would be
temporary.
2. The temporary variation in the incidence rates for
children in the 1-4 year age group, especially at age 3, may
be a random phenomenon. This could become clearer after a
longer observation period under the same conditions of
ascertainment.
3. Temporary changes in host-environment interactions.
Impressive demographic changes in relation to the health of
children have occurred in The Netherlands during and
before the period of study. Lower fertility rates (Table I)
have resulted in a decline of the birth rate, smaller families
and relatively more first-born children. In this period the
proportion of immigrant children from (former) Dutch
colonies as well as Mediterranean countries has risen from
5% to almost 15%. In general, housing conditions have
further improved. The control of infectious diseases has
improved through the various vaccination programmes, that
for measles being the last to be introduced in 1976, and the
use of more effective antibiotics. All this has undoubtedly led
to a lower risk of infection and may thus have resulted in a
lower mortality in the precancer phase (Kneale & Stewart,
1978).
Although the mortality rates for children in The
Netherlands were already low in 1970, an impressive and
steady decrease in these rates for the major causes of death,
including infectious diseases, has since occurred (Table VII).
According to the results of an extensive population-based
case-control study of (the same) children with ALL,
diagnosed in the 1973-1979 period, a risk-increasing
influence of 20% appeared to exist for higher socioeconomic
classes and 100% for first-borns. A decreased risk of 30%
was also established for exposure to serious infections in the
first year of life (van Steensel-Moll et al., 1986). Changes in
host-environment interactions were therefore substantial and
complex before and during the period of study. However,
according to the data of this study their impact on the
incidence of childhood leukaemia could only have been
small.
4. Temporary changes in risk factors should be taken into
account, especially for the birth cohort of 1978. From the
case-control study of ALL-patients (van Steensel-Moll et al.,
1985a, b) relative risks of about 2 were indeed found for
mothers exposed to prenatal X-rays, certain chemicals and
pregnancy-saving hormones. However, the contribution of
these factors to the risk of leukaemia could not exceed 10%.
In the period 1973-1979, space-time clustering (van Steensel-
Moll et al., 1983b) proved to be virtually absent for young
children with ALL. It can be concluded that there are no
concrete clues in this respect, particularly not for the three
small nuclear power plants.
Table V Distribution of immunological phenotype of childhood ALL in The Netherlands, according to WBC at
diagnosis: 1979-1986
Number of
leuocytes
x 109 l-1 No test No test
(WBC) T-cell Common ALL Pre-B B-cell Unclassifiablea resultb Total done
0- 4.9 3 132 14 0 7 26 182 51
5-19.9 6 130 23 2 11 6 182 66
20-49.9 6 41 18 1 4 3 73 20
50-99.9 7 20 9 2 1 1 40 13
>99.9 47 20 6 0 14 1 88 18
Unknown 1 2 0 0 0 0 3 2
Total 70 345 70 5 37 37 564 170
Total (%) 12.4 61.2 12.4 0.9 6.6 6.6 100
aImmunologically. "Due to lack of sufficient material.
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Table VI Incidence of childhood leukaemia in North and Western Europe, the United States
and Australia: From 1970
Cases per 105 per year
Per age group Ratio
Adjusted ALL
Population/country Period 0-4 5-9 10-14 0-14 ANLL
USA/SEER whites 73-82 6.8 3.5 2.3 4.4 5.4
USA/SEER blacks 73-82 3.4 2.0 2.0 2.5 2.9
Australia 77-82 7.4 3.6 2.2 4.6 5.3
Finland 71-82 5.4 3.0 2.7 3.9 5.0
West Germany 80-86 6.5 3.5 2.2 4.4 6.6
Denmark 80-84 5.7 2.7 2.8 3.9 5.3
Manchester UK 71-83 5.7 3.2 2.2 3.8 5.7
LRF-surveya UK 84-86 6.4 3.0 1.7 3.9 5.1
The Netherlands 73-86 6.1 3.1 1.9 3.9 8.3
aCases from: S.W. Scotland, Cumbria, Yorkshire, Trent, S.W. England, S. Wales and E.
Suffolk.
TableVII Relativechange inchildhood mortality inTheNetherlands,
1970-1985: All causes of death (A) and infectious diseases (B)
Cases per 105 per year by age group (1970-1972=100)
0 years 1-4 years 5-9 years
Period A B A B A B
70-72 1215 79.4 81.1 11.5 41.8 2.1
% % % % % %
70-72 100 100 100 100 100 100
73-75 92 91 89 83 87 90
76-78 81 93 74 52 81 71
79-81 70 64 68 38 64 67
82-84 69 74 62 35 45 52
85-86 55 39 51 31 42 48
Source: CBS, Department of Health Statistics.
It can be concluded that there are no satisfactory
explanations for either the observed temporary increase in
the incidence of common-ALL in young children in The
Netherlands or the difference in ALL in boys according to
degree of urbanisation. In view of the suggested effects of
demographic and socioeconomic changes on the incidence of
lymphoproliferative diseases (Ramot et al., 1984) and
common aetiological and diagnostic aspects, the DCLSG has
now started a study of the incidence of malignant lymphoma
in children in The Netherlands in the same period.
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